Enzo Clinical Labs appointed as participating laboratory in Empire BlueCross BlueShield provider network

Enzo Biochem Inc.'s (NYSE: ENZ) wholly-owned subsidiary, Enzo Clinical Labs, Inc., and Empire BlueCross BlueShield, the largest health insurer in New York State, today jointly announced that effective August 1, 2010 Enzo Clinical Labs will be a participating laboratory in the Empire provider network for the metropolitan New York area.

“Enzo Clinical Labs has demonstrated capabilities that will benefit the high level of healthcare which is our hallmark, and we are pleased to welcome them as a participating laboratory to our network”

The Empire provider network to be covered includes Empire PPO Plans, Empire EPO Plans and Empire Indemnity Plans. Enzo Clinical Labs provides clinical, cytology and anatomic pathology services, in addition to a comprehensive menu of genetic and ancillary testing, and customized test panels and profiles.

"We are very appreciative of being appointed a participating laboratory in the Empire provider network," said Kevin Krenitsky, M.D., President of Enzo Clinical Labs. "Empire BlueCross BlueShield is a major standard setter for quality patient healthcare, and similarly we at Enzo Labs' share a commitment to excellence and the use of advanced testing and technology to benefit patient care. We are thus proud of this new association, and look forward to contributing meaningfully to the services Empire provides."

"Enzo Clinical Labs has demonstrated capabilities that will benefit the high level of healthcare which is our hallmark, and we are pleased to welcome them as a participating laboratory to our network," said Jill R Hummel, Vice President, Health Services of Empire BlueCross BlueShield.